Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Adenocarcinoma
Circ_0000260 Regulates the Development and Deterioration of Gastric Adenocarcinoma with Cisplatin Resistance by Upregulating MMP11 via Targeting MiR-129-5p.
Adenocarcinoma
Correlation between Microvascular Density and Matrix Metalloproteinase 11 Expression in Prostate Cancer Tissues: a Preliminary Study in Thailand.
Adenocarcinoma
Extra- and Intracellular Imaging of human Matrix Metalloprotease 11 (hMMP-11) with a Cell-Penetrating FRET-Substrate.
Adenocarcinoma
Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.
Adenocarcinoma
Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
Adenocarcinoma
Matrix Metalloproteinase 11 as a Novel Tumor Promoter and Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.
Adenocarcinoma
MMP-11 and VEGF-C expression correlate with clinical features of colorectal adenocarcinoma.
Adenocarcinoma
Overexpression of Matrix Metalloproteinase 11 in Thai Prostatic Adenocarcinoma is Associated with Poor Survival.
Adenocarcinoma
Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma.
Adenocarcinoma
Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Adenocarcinoma of Lung
Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma.
Adenocarcinoma of Lung
Secreted phosphoprotein 1 upstream invasive network construction and analysis of lung adenocarcinoma compared with human normal adjacent tissues by integrative biocomputation.
Adenoma
A comparative study of E-cadherin and stromelysin-3 expression in de novo and ex adenoma carcinoma of the colorectum.
Adenoma
Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines.
Aortic Aneurysm, Thoracic
Cellular phenotype transformation occurs during thoracic aortic aneurysm development.
Arthritis, Rheumatoid
Expression of stromelysin 3 and tissue inhibitors of matrix metallo-proteinases, TIMP-1 and TIMP-2, in rheumatoid arthritis.
Astrocytoma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Atherosclerosis
Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.
Breast Diseases
Diagnostic value of Doppler ultrasound parameters combined with MMP-11 in early breast cancer and benign breast diseases.
Breast Neoplasms
An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.
Breast Neoplasms
Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer.
Breast Neoplasms
Assignment of the human stromelysin 3 (STMY3) gene to the q11.2 region of chromosome 22.
Breast Neoplasms
Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis.
Breast Neoplasms
Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer.
Breast Neoplasms
Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry.
Breast Neoplasms
Correlation between basic fibroblast growth factor immunostaining of stromal cells and stromelysin-3 mRNA expression in human breast carcinoma.
Breast Neoplasms
Correlation between stromelysin-3 mRNA level and outcome of human breast cancer.
Breast Neoplasms
Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis.
Breast Neoplasms
Diagnostic value of Doppler ultrasound parameters combined with MMP-11 in early breast cancer and benign breast diseases.
Breast Neoplasms
Distribution of stromelysin-3 mRNA transcripts and microvessels in human breast carcinomas.
Breast Neoplasms
Effect of different ERK2 protein localizations on prognosis of patients with invasive breast carcinoma.
Breast Neoplasms
Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.
Breast Neoplasms
Expression of cathepsin D, stromelysin-3, and urokinase by reactive stromal cells on breast carcinoma prognosis.
Breast Neoplasms
Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations.
Breast Neoplasms
Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues.
Breast Neoplasms
Expression of UTX Indicates Poor Prognosis in Patients With Luminal Breast Cancer and is Associated With MMP-11 Expression.
Breast Neoplasms
Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression.
Breast Neoplasms
Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ER? negative breast cancer cell lines.
Breast Neoplasms
Heterologous expression and functional characterization of matrix metalloproteinase-11 from canine mammary tumor.
Breast Neoplasms
High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma.
Breast Neoplasms
High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
Breast Neoplasms
Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3.
Breast Neoplasms
In vitro anti-metastatic activity of enterolactone, a mammalian lignan derived from flax lignan, and down-regulation of matrix metalloproteinases in MCF-7 and MDA MB 231 cell lines.
Breast Neoplasms
Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo.
Breast Neoplasms
Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
Breast Neoplasms
Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products.
Breast Neoplasms
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Breast Neoplasms
Matrix metalloproteinase stromelysin-3 in development and pathogenesis.
Breast Neoplasms
Matrix Metalloproteinase-11 Promotes Early Mouse Mammary Gland Tumor Growth through Metabolic Reprogramming and Increased IGF1/AKT/FoxO1 Signaling Pathway, Enhanced ER Stress and Alteration in Mitochondrial UPR.
Breast Neoplasms
MicroRNA-125b as a tumor suppressor by targeting MMP11 in breast cancer.
Breast Neoplasms
MMP-11 as a biomarker for metastatic breast cancer by immunohistochemical-assisted imaging mass spectrometry.
Breast Neoplasms
MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.
Breast Neoplasms
MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
Breast Neoplasms
MMP11 expression in intratumoral inflammatory cells in breast cancer.
Breast Neoplasms
MMP11 promotes the proliferation and progression of breast cancer through stabilizing Smad2 protein.
Breast Neoplasms
Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells.
Breast Neoplasms
Multimodal laser ablation/desorption imaging analysis of Zn and MMP-11 in breast tissues.
Breast Neoplasms
New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells.
Breast Neoplasms
New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells.
Breast Neoplasms
Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
Breast Neoplasms
Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer.
Breast Neoplasms
Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Breast Neoplasms
Prospective-study of stromelysin-3 expression in breast-cancer biopsies and disease-free survival.
Breast Neoplasms
Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.
Breast Neoplasms
Protein Tyrosine Kinase 7 Regulates EGFR/Akt Signaling Pathway and Correlates With Malignant Progression in Triple-Negative Breast Cancer.
Breast Neoplasms
Regulation of extracellular matrix remodeling and cell fate determination by matrix metalloproteinase stromelysin-3 during thyroid hormone-dependent post-embryonic development.
Breast Neoplasms
Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.
Breast Neoplasms
Requirement for matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis.
Breast Neoplasms
Stimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell lines.
Breast Neoplasms
Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
Breast Neoplasms
Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
Breast Neoplasms
Stromelysin-3 and other stromelysins in breast cancer: importance of epithelial-stromal interactions during tumor progression.
Breast Neoplasms
Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction.
Breast Neoplasms
Stromelysin-3 expression in breast cancer biopsies: clinico-pathological correlations.
Breast Neoplasms
Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior.
Breast Neoplasms
Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts.
Breast Neoplasms
Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Breast Neoplasms
Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
Breast Neoplasms
Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Breast Neoplasms
Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome.
Breast Neoplasms
Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
Breast Neoplasms
The Association of Serum IL-33 and sST2 with Breast Cancer.
Breast Neoplasms
The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis.
Breast Neoplasms
The clinical implications of MMP-11 and CK-20 expression in human breast cancer.
Breast Neoplasms
The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts.
Breast Neoplasms
[Proteases by reactive stromal cells in cancer: an attractive therapeutic target]
Breast Neoplasms
[Stromal proteases in the progression of breast cancer]
Carcinogenesis
Altered gene expression in conjunctival squamous cell carcinoma.
Carcinogenesis
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Carcinogenesis
Gastric cancer: basic aspects.
Carcinogenesis
High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.
Carcinogenesis
Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
Carcinogenesis
Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors.
Carcinogenesis
Matrix Metalloproteinase 11 as a Novel Tumor Promoter and Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.
Carcinogenesis
Matrix metalloproteinase-11 overexpressed in lobular carcinoma cells of the breast promotes anoikis resistance.
Carcinogenesis
Matrix Metalloproteinase-11 Promotes Early Mouse Mammary Gland Tumor Growth through Metabolic Reprogramming and Increased IGF1/AKT/FoxO1 Signaling Pathway, Enhanced ER Stress and Alteration in Mitochondrial UPR.
Carcinogenesis
Prevention of colitis-associated carcinogenesis with infliximab.
Carcinogenesis
Stromelysin-3 expression is an early event in human oral tumorigenesis.
Carcinogenesis
Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Carcinoid Tumor
Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Carcinoma
A comparative study of E-cadherin and stromelysin-3 expression in de novo and ex adenoma carcinoma of the colorectum.
Carcinoma
Altered gene expression in conjunctival squamous cell carcinoma.
Carcinoma
Amplification of stromelysin-3 transcripts from carcinomas of the colon.
Carcinoma
Association of expression of metalloproteinases and their inhibitors with the metastatic potential of squamous-cell lung carcinomas. A molecular and immunohistochemical study.
Carcinoma
Association of matrix metalloproteinase-11 polymorphisms with susceptibility and clinicopathologic characteristics for oral squamous cell carcinoma.
Carcinoma
Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing.
Carcinoma
Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Carcinoma
Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry.
Carcinoma
Circulating IgG response to stromelysin-3, collagenase-3, galectin-3 and mesothelin in patients with pharynx/larynx squamous cell carcinoma.
Carcinoma
Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Carcinoma
Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.
Carcinoma
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Carcinoma
Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma.
Carcinoma
Dual regulation of stromelysin-3 by fibroblast growth factor-2 in murine osteoblasts.
Carcinoma
E-cadherin, beta-catenin and stromelysin-3 expression in de novo carcinoma of the colorectum.
Carcinoma
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Carcinoma
Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines.
Carcinoma
Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas.
Carcinoma
Expression of stromelysin 3 in basal cell carcinomas.
Carcinoma
Expression of stromelysin 3 in keratoarcanthoma and squamous cell carcinoma.
Carcinoma
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Carcinoma
Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review.
Carcinoma
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Carcinoma
From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation.
Carcinoma
High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.
Carcinoma
High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma.
Carcinoma
Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities.
Carcinoma
Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
Carcinoma
Improved design of riboprobes from pBluescript and related vectors for in situ hybridization.
Carcinoma
Increased expression of stromelysin-3 in basal cell carcinomas.
Carcinoma
Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Carcinoma
Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.
Carcinoma
Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas.
Carcinoma
Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch.
Carcinoma
Matrix metalloproteinase 11/stromelysin-3 exerts both activator and repressor functions during the hematogenous metastatic process in mice.
Carcinoma
Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
Carcinoma
Matrix-metalloproteinases in bronchopulmonary carcinomas.
Carcinoma
Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.
Carcinoma
MMP-11 promoted the oral cancer migration and Fak/Src activation.
Carcinoma
MMP11: a novel target antigen for cancer immunotherapy.
Carcinoma
mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas.
Carcinoma
Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
Carcinoma
Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Carcinoma
Requirement for matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis.
Carcinoma
Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer.
Carcinoma
Significance of MMP11 and P14(ARF) expressions in clinical outcomes of patients with laryngeal cancer.
Carcinoma
Stromal factors involved in human prostate cancer development, progression and castration resistance.
Carcinoma
Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines.
Carcinoma
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Carcinoma
Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
Carcinoma
Stromelysin-3 expression in breast cancer biopsies: clinico-pathological correlations.
Carcinoma
Stromelysin-3 expression in early (pT1) carcinomas and pseudoinvasive lesions of the colorectum.
Carcinoma
Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential.
Carcinoma
Stromelysin-3 expression in noninvasive and invasive neoplasms of the urinary bladder.
Carcinoma
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Carcinoma
Stromelysin-3 expression promotes tumor take in nude mice.
Carcinoma
Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior.
Carcinoma
Stromelysin-3 induction and interstitial collagenase repression by retinoic acid. Therapeutical implication of receptor-selective retinoids dissociating transactivation and AP-1-mediated transrepression.
Carcinoma
Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Carcinoma
Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Carcinoma
Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progression.
Carcinoma
Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma.
Carcinoma
Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
Carcinoma
Transcriptional induction of stromelysin-3 in mesodermal cells is mediated by an upstream CCAAT/enhancer-binding protein element associated with a DNase I-hypersensitive site.
Carcinoma
Transcriptional regulation of the Xenopus laevis Stromelysin-3 gene by thyroid hormone is mediated by a DNA element in the first intron.
Carcinoma
Tumor cell-mediated induction of the stromal factor stromelysin-3 requires heterotypic cell contact-dependent activation of specific protein kinase C isoforms.
Carcinoma
[Expression and clinical significance of stromelysin-3 in laryngeal cancer]
Carcinoma
[Stromal proteases in the progression of breast cancer]
Carcinoma in Situ
Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Carcinoma, Basal Cell
Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing.
Carcinoma, Basal Cell
Expression of stromelysin 3 in basal cell carcinomas.
Carcinoma, Basal Cell
Expression of stromelysin 3 in keratoarcanthoma and squamous cell carcinoma.
Carcinoma, Basal Cell
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Carcinoma, Basal Cell
Increased expression of stromelysin-3 in basal cell carcinomas.
Carcinoma, Basal Cell
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Carcinoma, Basal Cell
Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Carcinoma, Basal Cell
Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma.
Carcinoma, Ductal
Diagnostic and Prognostic Relevance of MMP-11 Expression in the Stromal Fibroblast-Like Cells Adjacent to Invasive Ductal Carcinoma of the Breast.
Carcinoma, Ductal
Effect of different ERK2 protein localizations on prognosis of patients with invasive breast carcinoma.
Carcinoma, Ductal
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Carcinoma, Ductal
Stromelysin-3 expression in breast cancer biopsies: clinico-pathological correlations.
Carcinoma, Hepatocellular
Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.
Carcinoma, Hepatocellular
Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Carcinoma, Hepatocellular
LINC00221 silencing prevents the progression of hepatocellular carcinoma through let-7a-5p-targeted inhibition of MMP11.
Carcinoma, Hepatocellular
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf.
Carcinoma, Hepatocellular
Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
Carcinoma, Hepatocellular
Molecular mechanisms governing microRNA-125a expression in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Mutual suppression of miR-125a and Lin28b in human hepatocellular carcinoma cells.
Carcinoma, Intraductal, Noninfiltrating
Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.
Carcinoma, Intraductal, Noninfiltrating
Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events.
Carcinoma, Intraductal, Noninfiltrating
Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
Carcinoma, Lobular
Matrix metalloproteinase-11 overexpressed in lobular carcinoma cells of the breast promotes anoikis resistance.
Carcinoma, Medullary
Expression of stromelysin-3 in medullary carcinoma of the breast.
Carcinoma, Non-Small-Cell Lung
Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
[Prognostic impact of matrix metalloproteinases 2,9, and 11 in stromal cells stage I non-small cell lung cancer]
Carcinoma, Renal Cell
Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma.
Carcinoma, Renal Cell
mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas.
Carcinoma, Squamous Cell
Circulating IgG response to stromelysin-3, collagenase-3, galectin-3 and mesothelin in patients with pharynx/larynx squamous cell carcinoma.
Carcinoma, Squamous Cell
Expression of stromelysin 3 in keratoarcanthoma and squamous cell carcinoma.
Carcinoma, Squamous Cell
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Carcinoma, Squamous Cell
Increased expression of stromelysin-3 in basal cell carcinomas.
Carcinoma, Squamous Cell
Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Cervical Intraepithelial Neoplasia
Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
Cholangiocarcinoma
High Expression of Matrix Metalloproteinase-11 indicates Poor Prognosis in Human Cholangiocarcinoma.
Colonic Neoplasms
Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
Colonic Neoplasms
Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells.
Colonic Neoplasms
Matrix-degrading metalloproteinases in tumor progression.
Colonic Neoplasms
MMP11: a novel target antigen for cancer immunotherapy.
Colonic Neoplasms
[Identification of protein markers for serum diagnosis of cancer based on microRNA expression profiling].
Colorectal Neoplasms
Amplification of stromelysin-3 transcripts from carcinomas of the colon.
Colorectal Neoplasms
Clinicopathological significance of stromelysin-3 expression in colorectal cancer.
Colorectal Neoplasms
Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
Colorectal Neoplasms
Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features.
Colorectal Neoplasms
Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer.
Colorectal Neoplasms
Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes.
Colorectal Neoplasms
Stromelysin-3 (ST-3) mRNA expression in colorectal carcinomas. Localization and clinicopathologic correlations.
Deafness
Fine genetic and comparative mapping of the deafness mutation Ames waltzer on mouse chromosome 10.
Dermatofibrosarcoma
Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans.
Dermatofibrosarcoma
Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans.
Dermatofibrosarcoma
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Dermatofibrosarcoma
Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Diabetes Mellitus, Type 2
Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch.
Endometrial Hyperplasia
Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Endometrial Neoplasms
Expression of cysteine protease cathepsin L is increased in endometrial cancer and correlates with expression of growth regulatory genes.
Endometrial Neoplasms
Overexpression of the matrix metalloproteinase 11 gene is a potential biomarker for type 1 endometrial cancer.
Endometriosis
Analysis of differences in the transcriptomic profiles of eutopic and ectopic endometriums in women with ovarian endometriosis.
Endometriosis
Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2.
Endometriosis
External validation of putative biomarkers in eutopic endometrium of women with endometriosis using NanoString technology.
Esophageal Neoplasms
Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Esophageal Neoplasms
Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Esophageal Squamous Cell Carcinoma
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Fibromatosis, Aggressive
Invasion and MMP expression profile in desmoid tumours.
Glioblastoma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Glioblastoma
Norepinephrine inhibits migration and invasion of human glioblastoma cell cultures possibly via MMP-11 inhibition.
Glioma
Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.
Glioma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Glomerulonephritis
The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis.
Granulomatosis with Polyangiitis
The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis.
Hemangioma
Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas.
Histiocytoma, Benign Fibrous
Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans.
Histiocytoma, Benign Fibrous
Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium.
Histiocytoma, Benign Fibrous
Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans.
Histiocytoma, Benign Fibrous
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Histiocytoma, Benign Fibrous
Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Infertility
Analysis of differences in the transcriptomic profiles of eutopic and ectopic endometriums in women with ovarian endometriosis.
Insulin Resistance
Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance.
Intervertebral Disc Degeneration
Evaluation of the Association Between Matrix Metalloproteinase 11 and Intervertebral Disc Disease.
Laryngeal Neoplasms
Significance of MMP11 and P14(ARF) expressions in clinical outcomes of patients with laryngeal cancer.
Laryngeal Neoplasms
Stromelysin-3 mRNA expression in dysplasias and invasive epithelial cancer of the larynx.
Laryngeal Neoplasms
[Expression and clinical significance of stromelysin-3 in laryngeal cancer]
Leiomyoma
Extracellular matrix remodeling and inflammatory pathway in human endometrium: insights from uterine leiomyomas.
Leiomyoma
Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium.
Leukemia
Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas.
Lung Neoplasms
Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer.
Lung Neoplasms
Regulation of lung cancer cell growth and invasiveness by beta-TRCP.
Lung Neoplasms
Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts.
Lung Neoplasms
The Association of MMP-11 Promoter Polymorphisms With Susceptibility to Lung Cancer in Taiwan.
Lung Neoplasms
[Prognostic impact of matrix metalloproteinases 2,9, and 11 in stromal cells stage I non-small cell lung cancer]
Lymphatic Metastasis
CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells.
Lymphatic Metastasis
Corrigendum to "CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells" [Int. J. Biochem. Cell Biol. 39 (2007) 2135-2142].
Lymphatic Metastasis
Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
Lymphatic Metastasis
Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features.
Lymphatic Metastasis
Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Lymphatic Metastasis
Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
Lymphatic Metastasis
MMP-11 promoted the oral cancer migration and Fak/Src activation.
Lymphatic Metastasis
siRNA targeted against matrix metalloproteinase 11 inhibits the metastatic capability of murine hepatocarcinoma cell Hca-F to lymph nodes.
Lymphatic Metastasis
The clinical implications of MMP-11 and CK-20 expression in human breast cancer.
Lymphoma
Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas.
matrix metalloproteinase-11 deficiency
Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors.
Melanoma
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Meningioma
Stromelysin-3 is expressed by aggressive meningiomas.
Metabolic Syndrome
Cultured human peripheral blood mononuclear cells alter their gene expression when challenged with endocrine-disrupting chemicals.
Metabolic Syndrome
Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch.
Microscopic Polyangiitis
The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis.
Mouth Neoplasms
MMP-11 promoted the oral cancer migration and Fak/Src activation.
Mouth Neoplasms
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Mucocutaneous Lymph Node Syndrome
Association between polymorphisms of matrix metalloproteinase 11 (MMP-11) and Kawasaki disease in the Korean population.
Nasal Polyps
Elevated S100A9 expression in chronic rhinosinusitis coincides with elevated MMP production and proliferation in vitro.
Neoplasm Metastasis
Clinicopathological significance of stromelysin-3 expression in colorectal cancer.
Neoplasm Metastasis
Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Neoplasm Metastasis
Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer.
Neoplasm Metastasis
Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis.
Neoplasm Metastasis
Diagnostic and Prognostic Relevance of MMP-11 Expression in the Stromal Fibroblast-Like Cells Adjacent to Invasive Ductal Carcinoma of the Breast.
Neoplasm Metastasis
Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma.
Neoplasm Metastasis
Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.
Neoplasm Metastasis
Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
Neoplasm Metastasis
Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression.
Neoplasm Metastasis
Expression and Clinical Significance of Metalloproteases and Their Inhibitors by Endothelial Cells From Invasive Breast Carcinomas.
Neoplasm Metastasis
Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features.
Neoplasm Metastasis
From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation.
Neoplasm Metastasis
Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
Neoplasm Metastasis
Gene Expression Profiling of Breast Cancer Brain Metastasis.
Neoplasm Metastasis
Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ER? negative breast cancer cell lines.
Neoplasm Metastasis
High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
Neoplasm Metastasis
Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
Neoplasm Metastasis
Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Neoplasm Metastasis
Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
Neoplasm Metastasis
In vitro anti-metastatic activity of enterolactone, a mammalian lignan derived from flax lignan, and down-regulation of matrix metalloproteinases in MCF-7 and MDA MB 231 cell lines.
Neoplasm Metastasis
Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
Neoplasm Metastasis
Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
Neoplasm Metastasis
Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer.
Neoplasm Metastasis
Matrix metalloproteinase 11/stromelysin-3 exerts both activator and repressor functions during the hematogenous metastatic process in mice.
Neoplasm Metastasis
Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
Neoplasm Metastasis
Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
Neoplasm Metastasis
MicroRNA miR-24 Enhances Tumor Invasion and Metastasis by Targeting PTPN9 and PTPRF to Promote EGF Signaling.
Neoplasm Metastasis
MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Neoplasm Metastasis
MMP-11 and VEGF-C expression correlate with clinical features of colorectal adenocarcinoma.
Neoplasm Metastasis
MMP-11 as a biomarker for metastatic breast cancer by immunohistochemical-assisted imaging mass spectrometry.
Neoplasm Metastasis
MMP-11 promoted the oral cancer migration and Fak/Src activation.
Neoplasm Metastasis
New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment.
Neoplasm Metastasis
Overexpression of Matrix Metalloproteinase 11 in Thai Prostatic Adenocarcinoma is Associated with Poor Survival.
Neoplasm Metastasis
Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Neoplasm Metastasis
Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis.
Neoplasm Metastasis
Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.
Neoplasm Metastasis
siRNA targeted against matrix metalloproteinase 11 inhibits the metastatic capability of murine hepatocarcinoma cell Hca-F to lymph nodes.
Neoplasm Metastasis
Stromelysin-3 gene expression in human cancer: an overview.
Neoplasm Metastasis
The clinical implications of MMP-11 and CK-20 expression in human breast cancer.
Neoplasm Metastasis
The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts.
Neoplasm Metastasis
The paradoxical role of matrix metalloproteinase-11 in cancer.
Neoplasm Metastasis
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.
Neoplasm Metastasis
[Expression and clinical significance of stromelysin-3 in laryngeal cancer]
Neoplasm Micrometastasis
Amplification of stromelysin-3 transcripts from carcinomas of the colon.
Neoplasms
A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas.
Neoplasms
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential.
Neoplasms
A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.
Neoplasms
Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness.
Neoplasms
Altered gene expression in conjunctival squamous cell carcinoma.
Neoplasms
Alternative splicing and promoter usage generates an intracellular stromelysin 3 isoform directly translated as an active matrix metalloproteinase.
Neoplasms
Amplification of stromelysin-3 transcripts from carcinomas of the colon.
Neoplasms
An assessment of MMP and TIMP gene expression in cell lines and stroma - tumour differences in microdissected breast cancer biopsies.
Neoplasms
An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.
Neoplasms
Analysis of differences in the transcriptomic profiles of eutopic and ectopic endometriums in women with ovarian endometriosis.
Neoplasms
Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.
Neoplasms
Andrographolide induces DNA damage in prostate cancer cells.
Neoplasms
Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle.
Neoplasms
Cancer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion.
Neoplasms
Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis.
Neoplasms
CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells.
Neoplasms
Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer.
Neoplasms
Characterization of gene expression in major types of salivary gland carcinomas with epithelial differentiation.
Neoplasms
Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases.
Neoplasms
Circulating IgG response to stromelysin-3, collagenase-3, galectin-3 and mesothelin in patients with pharynx/larynx squamous cell carcinoma.
Neoplasms
Circ_0000260 Regulates the Development and Deterioration of Gastric Adenocarcinoma with Cisplatin Resistance by Upregulating MMP11 via Targeting MiR-129-5p.
Neoplasms
Clinicopathological significance of stromelysin-3 expression in colorectal cancer.
Neoplasms
Coexpression of stromelysin-3 and insulin-like growth factor II in tumors of ectodermal, mesodermal, and endodermal origin: indicator of a fetal cell phenotype.
Neoplasms
Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Neoplasms
Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer.
Neoplasms
Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.
Neoplasms
Correlation between Microvascular Density and Matrix Metalloproteinase 11 Expression in Prostate Cancer Tissues: a Preliminary Study in Thailand.
Neoplasms
Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.
Neoplasms
Diagnostic and Prognostic Relevance of MMP-11 Expression in the Stromal Fibroblast-Like Cells Adjacent to Invasive Ductal Carcinoma of the Breast.
Neoplasms
Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma.
Neoplasms
Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.
Neoplasms
Distribution of stromelysin-3 mRNA transcripts and microvessels in human breast carcinomas.
Neoplasms
Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
Neoplasms
Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
Neoplasms
Epithelial Mesenchymal Transition (EMT) in Metastatic Breast Cancer in Omani Women.
Neoplasms
Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression.
Neoplasms
Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer.
Neoplasms
Expression and purification of human stromelysin 1 and 3 from baculovirus-infected insect cells.
Neoplasms
Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma.
Neoplasms
Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
Neoplasms
Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses.
Neoplasms
Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines.
Neoplasms
Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.
Neoplasms
Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events.
Neoplasms
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Neoplasms
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.
Neoplasms
Expression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive ability.
Neoplasms
Expression of stromelysin 3 in basal cell carcinomas.
Neoplasms
Expression of stromelysin 3 in keratoarcanthoma and squamous cell carcinoma.
Neoplasms
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Neoplasms
Expression of stromelysin-3 (matrix metalloproteinase-11) in macrophages of murine thymus following thymocyte apoptosis.
Neoplasms
Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.
Neoplasms
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Neoplasms
Expression of UTX Indicates Poor Prognosis in Patients With Luminal Breast Cancer and is Associated With MMP-11 Expression.
Neoplasms
Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia.
Neoplasms
Extra- and Intracellular Imaging of human Matrix Metalloprotease 11 (hMMP-11) with a Cell-Penetrating FRET-Substrate.
Neoplasms
Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14.
Neoplasms
Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells.
Neoplasms
Furin-dependent intracellular activation of the human stromelysin-3 zymogen.
Neoplasms
Gastric cancer: basic aspects.
Neoplasms
Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
Neoplasms
Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
Neoplasms
Gene Expression Profiling of Breast Cancer Brain Metastasis.
Neoplasms
Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
Neoplasms
Heterologous expression and functional characterization of matrix metalloproteinase-11 from canine mammary tumor.
Neoplasms
High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase.
Neoplasms
High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.
Neoplasms
High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
Neoplasms
Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells.
Neoplasms
HMGA1 and MMP-11 Are Overexpressed in Human Non-melanoma Skin Cancer.
Neoplasms
Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3.
Neoplasms
Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3.
Neoplasms
Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
Neoplasms
Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer.
Neoplasms
Identification of peptide substrates for human MMP-11 (stromelysin-3) using phage display.
Neoplasms
Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities.
Neoplasms
Identification of the Prognosis-Related lncRNAs and Genes in Gastric Cancer.
Neoplasms
Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer.
Neoplasms
Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.
Neoplasms
Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
Neoplasms
Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Neoplasms
Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
Neoplasms
In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy.
Neoplasms
Inflammation-related factors predicting prognosis of gastric cancer.
Neoplasms
Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo.
Neoplasms
Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
Neoplasms
Integrative analysis with expanded DNA methylation data reveals common key regulators and pathways in cancers.
Neoplasms
Invasion and MMP expression profile in desmoid tumours.
Neoplasms
Joint Tumor Bud-MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma.
Neoplasms
Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
Neoplasms
Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer.
Neoplasms
Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts.
Neoplasms
Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas.
Neoplasms
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf.
Neoplasms
Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors.
Neoplasms
Matrix Metalloproteinase 11 as a Novel Tumor Promoter and Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.
Neoplasms
Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells.
Neoplasms
Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis.
Neoplasms
Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma.
Neoplasms
Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch.
Neoplasms
Matrix metalloproteinase 11/stromelysin-3 exerts both activator and repressor functions during the hematogenous metastatic process in mice.
Neoplasms
Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of the extremities.
Neoplasms
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Neoplasms
Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
Neoplasms
Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
Neoplasms
Matrix Metalloproteinase-11 Promotes Early Mouse Mammary Gland Tumor Growth through Metabolic Reprogramming and Increased IGF1/AKT/FoxO1 Signaling Pathway, Enhanced ER Stress and Alteration in Mitochondrial UPR.
Neoplasms
Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions.
Neoplasms
Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines.
Neoplasms
Matrix-degrading metalloproteinases in tumor progression.
Neoplasms
Matrix-metalloproteinases in bronchopulmonary carcinomas.
Neoplasms
Metalloproteinase 11, potential marker and molecular target in advanced and castration-resistant prostate cancer. Culture study of peritumoral fibroblasts.
Neoplasms
MicroRNA miR-24 Enhances Tumor Invasion and Metastasis by Targeting PTPN9 and PTPRF to Promote EGF Signaling.
Neoplasms
MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11.
Neoplasms
MicroRNA-125b as a tumor suppressor by targeting MMP11 in breast cancer.
Neoplasms
MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple-negative breast cancer.
Neoplasms
MicroRNA-192 inhibits the proliferation, migration and invasion of osteosarcoma cells and promotes apoptosis by targeting matrix metalloproteinase-11.
Neoplasms
MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
Neoplasms
MMP-11 and VEGF-C expression correlate with clinical features of colorectal adenocarcinoma.
Neoplasms
MMP-11 as a biomarker for metastatic breast cancer by immunohistochemical-assisted imaging mass spectrometry.
Neoplasms
MMP-11 promoted the oral cancer migration and Fak/Src activation.
Neoplasms
MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.
Neoplasms
MMP11 promotes the proliferation and progression of breast cancer through stabilizing Smad2 protein.
Neoplasms
MMP11: a novel target antigen for cancer immunotherapy.
Neoplasms
Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells.
Neoplasms
Molecular mechanisms governing microRNA-125a expression in human hepatocellular carcinoma cells.
Neoplasms
mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas.
Neoplasms
Multimodal laser ablation/desorption imaging analysis of Zn and MMP-11 in breast tissues.
Neoplasms
Mutual suppression of miR-125a and Lin28b in human hepatocellular carcinoma cells.
Neoplasms
New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment.
Neoplasms
New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells.
Neoplasms
Norepinephrine inhibits migration and invasion of human glioblastoma cell cultures possibly via MMP-11 inhibition.
Neoplasms
Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
Neoplasms
Overexpression of Matrix Metalloproteinase 11 in Thai Prostatic Adenocarcinoma is Associated with Poor Survival.
Neoplasms
Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Neoplasms
Production of a bioactive recombinant chicken matrix metalloproteinase-11 peptide in Escherichia coli.
Neoplasms
Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
Neoplasms
Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Neoplasms
Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
Neoplasms
Prospective-study of stromelysin-3 expression in breast-cancer biopsies and disease-free survival.
Neoplasms
Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors.
Neoplasms
Reduced expression of collagen VI alpha 3 (COL6A3) confers resistance to inflammation-induced MCP1 expression in adipocytes.
Neoplasms
Regulation of extracellular matrix remodeling and cell fate determination by matrix metalloproteinase stromelysin-3 during thyroid hormone-dependent post-embryonic development.
Neoplasms
Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis.
Neoplasms
Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and tumor expression of metalloproteases and their inhibitors in invasive breast cancer.
Neoplasms
Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.
Neoplasms
Significance of MMP11 and P14(ARF) expressions in clinical outcomes of patients with laryngeal cancer.
Neoplasms
Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells.
Neoplasms
siRNA targeted against matrix metalloproteinase 11 inhibits the metastatic capability of murine hepatocarcinoma cell Hca-F to lymph nodes.
Neoplasms
Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
Neoplasms
Stimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell lines.
Neoplasms
Stromal factors involved in human prostate cancer development, progression and castration resistance.
Neoplasms
Stromal fibroblasts adjacent to invasive thyroid tumors: expression of gelatinase A but not stromelysin 3 mRNA.
Neoplasms
Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development.
Neoplasms
Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
Neoplasms
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Neoplasms
Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines.
Neoplasms
Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders.
Neoplasms
Stromelysin-3 and other stromelysins in breast cancer: importance of epithelial-stromal interactions during tumor progression.
Neoplasms
Stromelysin-3 expression in breast cancer biopsies: clinico-pathological correlations.
Neoplasms
Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential.
Neoplasms
Stromelysin-3 expression in noninvasive and invasive neoplasms of the urinary bladder.
Neoplasms
Stromelysin-3 expression is an early event in human oral tumorigenesis.
Neoplasms
Stromelysin-3 expression promotes tumor take in nude mice.
Neoplasms
Stromelysin-3 gene expression in human cancer: an overview.
Neoplasms
Stromelysin-3 induction and interstitial collagenase repression by retinoic acid. Therapeutical implication of receptor-selective retinoids dissociating transactivation and AP-1-mediated transrepression.
Neoplasms
Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front.
Neoplasms
Stromelysin-3 is expressed by aggressive meningiomas.
Neoplasms
Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Neoplasms
Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
Neoplasms
Stromelysin-3 mRNA expression in dysplasias and invasive epithelial cancer of the larynx.
Neoplasms
Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome.
Neoplasms
Stromelysin-3 suppresses tumor cell apoptosis in a murine model.
Neoplasms
Study of matrix metalloproteinases and their inhibitors in prostate cancer.
Neoplasms
The Association of Serum IL-33 and sST2 with Breast Cancer.
Neoplasms
The clinical implications of MMP-11 and CK-20 expression in human breast cancer.
Neoplasms
The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts.
Neoplasms
The paradoxical role of matrix metalloproteinase-11 in cancer.
Neoplasms
The proprotein convertases furin and PACE4 play a significant role in tumor progression.
Neoplasms
Toll-Like Receptor 4 and Matrix Metalloproteases 11 and 13 as Predictors of Tumor Recurrence and Survival in Stage II Colorectal Cancer.
Neoplasms
Tumor cell-mediated induction of the stromal factor stromelysin-3 requires heterotypic cell contact-dependent activation of specific protein kinase C isoforms.
Neoplasms
Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients.
Neoplasms
[Proteases by reactive stromal cells in cancer: an attractive therapeutic target]
Neoplasms
[Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis]
Obesity
Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesity.
Obesity
Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle.
Obesity
Cultured human peripheral blood mononuclear cells alter their gene expression when challenged with endocrine-disrupting chemicals.
Oligodendroglioma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Osteochondrodysplasias
Expression of Genes Encoding Extracellular Matrix Macromolecules and Metalloproteinases in Avian Tibial Dyschondroplasia.
Osteosarcoma
MicroRNA-192 inhibits the proliferation, migration and invasion of osteosarcoma cells and promotes apoptosis by targeting matrix metalloproteinase-11.
Ovarian Neoplasms
Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer.
Ovarian Neoplasms
Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer.
Pancreatic Neoplasms
Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.
Pancreatic Neoplasms
Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer.
Pancreatic Neoplasms
Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
Pancreatic Neoplasms
Matrix Metalloproteinase 11 as a Novel Tumor Promoter and Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.
Pancreatic Neoplasms
Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
Pancreatic Neoplasms
Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines.
Papillomavirus Infections
Co-expression of metalloproteinases 11 and 12 in cervical scrapes cells from cervical precursor lesions.
Prostatic Neoplasms
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients.
Prostatic Neoplasms
Correlation between Microvascular Density and Matrix Metalloproteinase 11 Expression in Prostate Cancer Tissues: a Preliminary Study in Thailand.
Prostatic Neoplasms
Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.
Skin Neoplasms
HMGA1 and MMP-11 Are Overexpressed in Human Non-melanoma Skin Cancer.
Squamous Cell Carcinoma of Head and Neck
Association of matrix metalloproteinase-11 polymorphisms with susceptibility and clinicopathologic characteristics for oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
MMP-11 promoted the oral cancer migration and Fak/Src activation.
Squamous Cell Carcinoma of Head and Neck
Significance of MMP11 and P14(ARF) expressions in clinical outcomes of patients with laryngeal cancer.
Squamous Cell Carcinoma of Head and Neck
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Stomach Neoplasms
Cellular prion protein promotes invasion and metastasis of gastric cancer.
Stomach Neoplasms
Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression.
Stomach Neoplasms
Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
Stomach Neoplasms
IGF-1-induced MMP-11 expression promotes the proliferation and invasion of gastric cancer cells through the JAK1/STAT3 signaling pathway.
Stomach Neoplasms
Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
Stomach Neoplasms
Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
Stomach Neoplasms
LncRNA CTBP1-AS2 Facilitates Gastric Cancer Progression via Regulating the miR-139-3p/MMP11 Axis.
Stomach Neoplasms
Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells.
Stomach Neoplasms
Matrix metalloproteinase gene expressions might be oxidative stress targets in gastric cancer cell lines.
Stomach Neoplasms
Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
Stomach Neoplasms
UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability.
Synovitis
Expression of stromelysin 3 and tissue inhibitors of matrix metallo-proteinases, TIMP-1 and TIMP-2, in rheumatoid arthritis.
Tendinopathy
Epigenetic Status of The Human MMP11 Gene Promoter is Altered in Patellar Tendinopathy.
Thromboangiitis Obliterans
Increased serum HMGB-1, ICAM-1 and Metalloproteinase-9 levels in Buerger's patients.
Thrombosis
Expression changes and roles of matrix metalloproteinases in a rat model of traumatic deep vein thrombosis.
Thyroid Cancer, Papillary
Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
Thyroid Cancer, Papillary
Inverse relationships between the expression of MMP-7 and MMP-11 and predictors of poor prognosis of papillary thyroid carcinoma.
Thyroid Cancer, Papillary
miR-125a-3p suppresses the growth and progression of papillary thyroid carcinoma cell by targeting MMP11.
Thyroid Cancer, Papillary
[Gene expression of metalloproteinase 11, claudin 1 and selected adhesion related genes in papillary thyroid cancer.]
Thyroid Neoplasms
MMP-11 promotes papillary thyroid cell proliferation and invasion via the NF-?B pathway.
Thyroid Neoplasms
[Gene expression of metalloproteinase 11, claudin 1 and selected adhesion related genes in papillary thyroid cancer.]
Triple Negative Breast Neoplasms
MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple-negative breast cancer.
Urinary Bladder Neoplasms
Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis.
Urinary Bladder Neoplasms
Promoter analysis of epigenetically controlled genes in bladder cancer.
Usher Syndromes
Fine genetic and comparative mapping of the deafness mutation Ames waltzer on mouse chromosome 10.
Uterine Cervical Neoplasms
Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
Uterine Cervical Neoplasms
[The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Vascular Malformations
Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas.
Vascular System Injuries
Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation.
Vasculitis
The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3.4.24.B3 matrix metalloproteinase-11
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
